Finished product reference
Rubidium (81rb) / Krypton (81mkr)
Gas · Respiratory · 12 mCi
- List code
- 52651
- Pharmacologic class
- Radiopharmaceutical: rubidium-81/krypton-81m generator (diagnostic gas)
What it is and how it works
Rubidium-81 (half-life about 4.6 hours) decays to krypton-81m, an inert radioactive gas with a half-life of about 13 seconds that emits gamma radiation suitable for imaging. Eluted from the generator with humidified air or oxygen and inhaled continuously, krypton-81m distributes in proportion to regional ventilation and decays almost immediately, giving a very low radiation dose.
Indications
Lung ventilation scintigraphy, usually combined with perfusion imaging, for the diagnosis of pulmonary embolism and assessment of regional lung function.
Dosage and administration (summary)
Administered by continuous inhalation from the generator during imaging in a nuclear medicine department; the activity used is determined by the imaging protocol.
Contraindications
No specific contraindications are generally recognised; the need for the examination should be considered carefully in pregnancy.
Warnings and precautions
Generator elution and inhalation must be performed by trained staff in accordance with radiation-protection regulations. Because of the short generator shelf life, use must be scheduled within the stated expiry.
Pregnancy
Radiation dose to the fetus is very low, but the examination should be performed only when clearly indicated.
Storage and supply
Store the generator in its shielding at room temperature according to the manufacturer’s instructions and radiation-protection regulations.
Source: reference summary prepared from the EU SmPC/EPAR, BNF and WHO Model Formulary. The approved product information in Iran governs.
Reference information for professional sourcing and registration enquiries, not medical advice or a promotion. Drug information is condensed from US FDA prescribing information (public domain, via openFDA and DailyMed) and does not replace the product’s approved labelling in Iran. Availability, origin and documentation are confirmed per enquiry.
Tell us the quantity, the market and the timing.
Send the molecule or ingredient, the specification and the destination. We reply from Tehran with the questions, the documents and the next step.